FDA Approves Drug that Lowers Number of Migraine Days Per Month The U.S. Food and Drug Administration has now a drug called erenumab-aooe and marketed as Aimovig, for the preventive treatment of migraine in adults. The self-injection drug, Aimovig, is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity […]

The post FDA Approves Migraine Drug that Lowers Number of Migraine Days Per Month appeared first on BioTecNika .Read more at www.biotecnika.org/2018/05/fda-approves-drug-that-lowers-number-of-migraine-days-per-month/